ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,726.42
      -0.11%
      US Tech 100
      19,478.40
      0.33%
      Dow Jones
      41,986.59
      -0.53%
      Brent Oil
      73.375
      -1.59%
      Bitcoin
      63,519.17
      -1.17%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Altimmune Inc (ALT)

      7. Altimmune Inc (ALT) Financials

      Altimmune Inc

      Altimmune Inc (ALT)

      Analytica Limited
      Altitude Group Plc
      Alturas Minerals Corp
      7.0597
      -0.0603
      ( -0.85% )
      Updated: 11:41:33
      Delayed by 15 minutes

      Altimmune Inc Financial Summary

      The current ALT market cap is 501.74M. The company's latest EPS is USD -1.2445 and P/E is -5.74.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 6k362k37k5k5k
      Operating Income -18.01M-22.54M-33.62M-26.79M-26.75M
      Net Income -16.06M-20.67M-31.64M-24.39M-24.64M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 5.8M8.19M4.41M-68k426k
      Operating Income -20.47M-54.8M-85.92M-87.74M-95.93M
      Net Income -20.97M-49.04M-97.09M-84.71M-88.45M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 183.32M166.57M210.64M188.36M173.35M
      Total Liabilities 15.6M16.18M16.54M15.42M20.82M
      Total Equity 167.71M150.4M194.1M172.94M152.53M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 54.06M245.12M218.87M206.93M210.64M
      Total Liabilities 8.54M19.24M19.73M21.64M16.54M
      Total Equity 45.52M225.88M199.14M185.29M194.1M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -38.79M-59.28M-75.81M-16.36M-34.47M
      Investing 17.29M21.69M13.73M-39.52M-43.22M
      Financing 12.76M13.35M86.11M-261k-307k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -9.6M-34.44M-78.24M-62.59M-75.81M
      Investing -28.29M-72.1M87.52M-73.4M13.73M
      Financing 12.53M213.49M65.1M56.78M86.11M

      Stats and Ratios

      Market Cap 501.74M
      Price to Earnings Ratio -5.74
      Price to Sales Ratio 1.19k
      Price to Cash Ratio 3.76
      Price to Book Ratio 2.61
      Dividend Yield -

      Share Statistics

      Shares Outstanding 71.07M
      Average Volume (1 week) 2.39M
      Average Volume (1 Month) 2.32M
      52 Week Change 176.85%
      52 Week High 14.84
      52 Week Low 2.09
      Spread (Intraday) 0.01 (0.14%)

      Company Info

      Company Name Altimmune Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.altimmune.com
      Industry pharmaceutical preparations (2834)

      Your Recent History

      NASDAQ
      ALT
      Altimmune
      Delayed Upgrade Clock